Sudden cardiac death triggered by minimal alcohol consumption in the context of novel PPA2 mutations in 2 unrelated families.
Cristina G��mez Gonz��lez, Iv��n Del Campo Cano, Ana Isabel Fern��ndez-Avila, Maria Paz Su��rez-Mier, Mar��a Jos�� Sagastiz��bal, Reyes ��lvarez Garc��a-Rov��s, Irene M��ndez Fern��ndez, Silvia Vilches, Miriam Centeno Jim��nez, Ana Siles S��nchez-Manjavacas, Ana Usano Carrasco, Emiliano Gonzalez-Vioque, Juan Pablo Ochoa, Constancio Medrano, Esther Gonz��lez L��pez, Pablo Garc��a-Pav��a, Javier Bermejo, Mar��a Angeles Espinosa Castro
Author Information
Cristina G��mez Gonz��lez: Department of Cardiology, Hospital General Universitario Gregorio Mara����n, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; CIBERCV, Spain.
Iv��n Del Campo Cano: Department of Pediatrics, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; IDIPHISA, Madrid, Spain.
Ana Isabel Fern��ndez-Avila: Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; CIBERCV, Spain. Electronic address: anaisabel.fernandez@cibercv.es.
Maria Paz Su��rez-Mier: Servicio de Histopatolog��a. Instituto Nacional de Toxicolog��a y Ciencias Forenses. Madrid. Spain.
Mar��a Jos�� Sagastiz��bal: Instituto de Medicina Legal y Ciencias Forenses de Madrid, Spain.
Reyes ��lvarez Garc��a-Rov��s: Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; Pediatric Cardiology Department, Hospital General Universitario Gregorio Mara����n, Madrid, Spain.
Irene M��ndez Fern��ndez: Department of Cardiology, Hospital General Universitario Gregorio Mara����n, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; CIBERCV, Spain.
Silvia Vilches: Department of Cardiology, Hospital General Universitario Gregorio Mara����n, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; CIBERCV, Spain.
Miriam Centeno Jim��nez: Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; Pediatric Cardiology Department, Hospital General Universitario Gregorio Mara����n, Madrid, Spain.
Ana Siles S��nchez-Manjavacas: Department of Pediatrics, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; IDIPHISA, Madrid, Spain.
Ana Usano Carrasco: Department of Pediatrics, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; IDIPHISA, Madrid, Spain.
Emiliano Gonzalez-Vioque: Department of Biochemistry, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Juan Pablo Ochoa: Health in Code. A Coru��a. Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Constancio Medrano: Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; Pediatric Cardiology Department, Hospital General Universitario Gregorio Mara����n, Madrid, Spain.
Esther Gonz��lez L��pez: CIBERCV, Spain; IDIPHISA, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Pablo Garc��a-Pav��a: CIBERCV, Spain; IDIPHISA, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Department of Cardiology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Javier Bermejo: Department of Cardiology, Hospital General Universitario Gregorio Mara����n, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; CIBERCV, Spain.
Mar��a Angeles Espinosa Castro: Department of Cardiology, Hospital General Universitario Gregorio Mara����n, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto de Investigaci��n Sanitaria Gregorio Mara����n, Madrid, Spain; CIBERCV, Spain.
Biallelic variants in PPA2 gene cause a rare but lethal mitochondrial disorder. We describe the first four cases reported in Spain of PPA2 disease in two unrelated families. We have conducted a revision of the clinical history, necropsies, and postmortem genetic testing from probands, and clinical evaluation, genetic testing and blood transcript analysis in family members. All the cases harbored biallelic PPA2 variants in compound heterozygous status. Two brothers from family 1 suffered sudden death after a small first intake of alcohol in 2013 and 2022. The sister remains alive but affected with cardiomyopathy, extensive scar on cardiac imaging, and high sensitivity to alcohol intake. The three siblings carried PPA2 c.290A > G (p.Glu97Gly) novel missense variant and PPA2 c.513C > T (p.Cys171 = ) altering splicing site variant, both probably leading to mRNA degradation based on in-silico and transcript analyses. A teenager from family 2 suffered sudden death after a small intake of alcohol in 2018 and carried PPA2 c.683C > T (p.Pro228Leu) missense and PPA2 c.980_983del (p.Gln327fs) novel frameshift variant, both probably leading to abnormal protein structure. All cases were asymptomatic until adolescence. Furthermore, the sister in family 1 has survived as an asymptomatic adult. PPA2 disease can manifest as cardiac arrest in the young, especially after alcohol exposure. Our results show that PPA2 deficiency can be related to different pathogenicity mechanisms such as abnormal protein structure but also mRNA decay caused by synonymous or missense variants. Strict avoidance of alcohol consumption and early defibrillator implantation might prevent lethal arrhythmias in patients at risk.